Search

everythinglearnresearchcommunity

for

Search:↓

Retinoic acid affects male and female muscle energy use and function differently.

Frontal Fibrosing Alopecia may be a complex condition linked to hormonal changes in women, not just a form of Lichen Planopilaris.

Testosterone reduces key molecules needed for early pregnancy in rats.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Minoxidil, a common hair loss treatment, might work by counteracting a hormone that reduces hair growth and promotes hair loss.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

A certain mutation in the fetal alpha 5-reductase gene is linked to a higher risk of late miscarriage.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Humans can accurately guess age from faces, with women being slightly better at it, and age perception is linked to evolutionary factors.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Early sexual development in children, especially girls, can be treated with hormone therapy to improve adult height and requires support for the child and family.

Canrenone effectively reduced hair growth and testosterone levels in women with excessive hairiness.

Benzodiazepines changed hormone levels but did not affect hair growth in women with idiopathic hirsutism.

Vitamin D deficiency is linked to a higher chance of metabolic syndrome in women with PCOS.

Men who went through puberty later had lower sperm counts and altered hormone levels, possibly affecting fertility.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Many women with polycystic ovary syndrome have normal blood sugar, but some may have higher blood sugar levels or diabetes, especially if they are older, overweight, and have certain hormone levels.

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

Hormone testing may not be very helpful in diagnosing female pattern hair loss.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Some supplements and hormones can increase hair loss by raising DHT levels.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.